Teleflex Incorporated uses the ticker symbol (TFX) to find that there are now a total of 11 analysts covering the stock. The consensus rating is "Buy". The range between the high target price and the low target price is between 486 and 415, and our average target price is calculated to be 462.55. Now calculated at the previous closing price of 320.35, this indicates that there is a potential upside of 44.4%. The 50-day moving average is 344.74, and the 200-day moving average is 386.94. The company's market value is 15.015 billion U.S. dollars. Company website: http://www.teleflex.com
Teleflex Incorporated designs, develops, manufactures and supplies disposable medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The vascular access products it provides include Arrow brand catheters, catheter navigation and tip positioning systems, and intraosseous access systems for intravenous treatment, blood pressure measurement, and blood sampling through a single puncture site. The company also provides interventional products, including various coronary catheters, structural heart therapies, and peripheral interventional and cardiac assist products for interventional cardiologists, radiologists, and vascular surgeons; and Arrow brand catheters, Guideline And Trapliner catheter, Manta vascular closure device and Arrow Oncontrol device. Provide anesthesia products, such as airway and pain management products, to support hospitals, emergency medicine, and military channels; and surgical products, including metal and polymer ligature clips, as well as those used in laparoscopic surgery, percutaneous surgery systems, and other surgical instruments Fascia closure surgery system. The company also provides interventional urology products, including the UroLift system, which is an invasive technology for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapy for various care environments, Spirometry and ventilation management products. Provide urological products such as urinary catheters, urinary collectors, and urinary catheter accessories, as well as surgical endo-urological products; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and the home care market. The company was founded in 1943 and is headquartered in Wayne, Pennsylvania.
You can now share this content on Stocktwits, just click on the logo below and add the code to the text to view.
The good news spread quickly (but only if you did it):
View all sustainability departments, PLCs and news »
View all funds, market insights and news »
You understand and agree that any content posted on this website does not constitute a recommendation that any particular securities, portfolio of securities, trading or investment strategies are suitable or suitable for any particular person. You further understand that neither the information provider nor its affiliates will provide you with personal advice on the nature, potential, desirability, value, or applicability of any specific stocks, shares, securities, portfolios, transactions, investment strategies or other matters. We publicly disclose that we and our contributors may have interests in the investments and/or service providers mentioned on this website, and we receive compensation from certain companies mentioned on this website.